How should I interpret a bacterial vaginosis (BV) marker score of 2 and manage a patient with vaginal discharge when nucleic‑acid amplification tests are negative for Candida, Trichomonas, Chlamydia trachomatis, and Neisseria gonorrhoeae?

Management of BV Marker Score of 2 with Negative STI Testing

Given a BV marker score of 2 (indeterminate) with negative testing for other pathogens, you should treat this patient empirically for bacterial vaginosis with metronidazole 500 mg orally twice daily for 7 days, as the clinical presentation of vaginal discharge with odor strongly suggests BV despite the indeterminate molecular score. 1

Interpretation of the BV Marker Score

• A total score of 2 is classified as "indeterminate" for BV, requiring integration of additional clinical data to establish the diagnosis 1
• Your patient has a high score (2) for Atopobium vaginae alone, which is a key BV-associated anaerobe, while the other two markers (BVAB-2 and Megasphaera) scored 0 1, 2
• The presence of vaginal discharge with odor is a critical clinical finding that, combined with the elevated Atopobium score, strongly supports a BV diagnosis 1

Why Treat Despite "Indeterminate" Score

• Molecular BV testing (like your 3-marker panel) has 78.7% sensitivity compared to 98.7% for clinical Amsel criteria, meaning molecular tests can miss clinically significant BV 3
• The symptom of malodorous discharge is highly specific for BV when other pathogens (Trichomonas, Candida, gonorrhea, chlamydia) are excluded 1
• Untreated BV can lead to serious complications including increased STI acquisition risk (including HIV) and pelvic inflammatory disease 2, 4

Recommended Treatment Regimen

First-line therapy: Metronidazole 500 mg orally twice daily for 7 days 5, 6, 5, 7, 1

Alternative regimens if needed:

• Metronidazole 2 g orally as a single dose (lower cure rate: 84% vs 95% for 7-day regimen) 7
• Clindamycin cream 2%, one applicator (5 g) intravaginally at bedtime for 7 days 7
• Metronidazole gel 0.75%, one applicator (5 g) intravaginally twice daily for 5 days 7

Critical patient counseling:

• Advise the patient to avoid all alcohol during treatment and for 24 hours after completing metronidazole therapy to prevent disulfiram-like reactions 7, 1

Why Other Diagnoses Are Excluded

• Trichomoniasis is ruled out by negative NAAT (sensitivity approaching 100%) 3, 8
• Vulvovaginal candidiasis is ruled out by negative Candida albicans and C. glabrata NAAT 3, 8
• STIs (gonorrhea and chlamydia) are excluded by negative NAAT testing 1
• The clinical presentation of odor without predominant pruritus further argues against candidiasis, which typically presents with pruritus as the dominant symptom 5, 1

Partner Management

Partner treatment is NOT indicated for bacterial vaginosis, as treating male partners has not been shown to prevent recurrence or alter clinical outcomes 7, 1

Common Pitfalls to Avoid

• Do not withhold treatment waiting for a "definitive" BV score of 3-6 when clinical symptoms strongly suggest BV—the indeterminate category exists precisely to prompt clinical correlation 1
• Do not assume absence of clue cells or whiff test means no BV if you haven't performed wet mount microscopy; molecular testing alone may miss cases 3, 4
• Do not treat asymptomatic patients with positive BV markers, as approximately 20% of asymptomatic women have BV by molecular testing and treatment is only indicated for symptomatic disease 7, 8
• Be aware that up to 79% of women with STIs have concurrent BV, so the negative STI panel doesn't exclude BV 9

Follow-Up Considerations

• No follow-up testing is needed if symptoms resolve after treatment 6, 5
• If symptoms persist or recur shortly after treatment, consider treatment failure and re-treat with metronidazole 500 mg twice daily for 7 days 5
• Recurrent BV (≥3 episodes per year) may require extended suppressive therapy, though this is beyond the scope of initial management 4